Soluble receptor for advanced glycation end products attenuates sepsis-associated acute kidney injury
These findings suggest that RAGE plays an important role in septic AKI, and its inhibition by sRAGE may be a potential therapeutic target for AKI in severe sepsis.
Authors
- Hye‐Young Kang (ORCID: https://orcid.org/0000-0003-3260-2623)
- Dong Ki Kim (ORCID: https://orcid.org/0000-0002-5195-7852)
- Tae‐Hyun Yoo (ORCID: https://orcid.org/0000-0002-9183-4507)
- Sun‐Young Park (ORCID: https://orcid.org/0000-0002-1894-2771)
- Jung Tak Park (ORCID: https://orcid.org/0000-0002-2325-8982)
- Bo Young Nam (ORCID: https://orcid.org/0000-0002-9037-8394)
- Shin‐Wook Kang (ORCID: https://orcid.org/0000-0002-5677-4756)
- Seung Hyeok Han (ORCID: https://orcid.org/0000-0001-7923-5635)
- Gyuri Kim (ORCID: https://orcid.org/0009-0000-5920-1593)
Institutions
- Seoul National University (KR)
- Yonsei University (KR)
- Samsung (South Korea) (KR)
Publication Details
- Journal
- Kidney Research and Clinical Practice
- Published
- 2025-08-08
- DOI
- https://doi.org/10.23876/j.krcp.25.072
- Citations
- 1
- Primary Topic
- Advanced Glycation End Products research
- Type
- article
- Field-Weighted Citation Impact
- 1.32
Funders
- Yonsei University
- Korean Society of Nephrology
- Yonsei University College of Medicine